Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies

Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies

Raymond Fong,1 Megan E Cavet,2 Heleen H DeCory,2 Jason L Vittitow31Manhattan Eye, Ear and Throat Hospital and Lenox Hill Hospital, New York, NY, USA; 2Medical Affairs, Bausch + Lomb, Rochester, NY, USA; 3Clinical Affairs, Bausch + Lomb, Bridgewater, NJ, USAPurpose: To evaluate the efficacy and safet...

Full description

Bibliographic Details
Main Authors: Fong R, Cavet ME, DeCory HH, Vittitow JL
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Clinical Ophthalmology
Subjects:
Cataract surgery
Postoperative pain
Postoperative inflammation
Loteprednol etabonate
Submicron
Integrated analysis
Online Access:https://www.dovepress.com/loteprednol-etabonate-submicron-ophthalmic-gel-038-dosed-three-times-d-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/loteprednol-etabonate-submicron-ophthalmic-gel-038-dosed-three-times-d-peer-reviewed-article-OPTH

Similar Items